Ephedra protects vascular endothelium cells from vinorelbine‐induced cytotoxicity by preserving endothelial nitric oxide synthase activity
Traditional & Kampo Medicine · 2015
DOI: 10.1002/tkm2.1024 ↗Abstract
ABSTRACT Aim Vinorelbine is an anticancer drug associated with vascular injury. The mechanism of vascular injury is associated with the decrease of endothelial nitric oxide synthase ( eNOS ), which regulates oxidative stress. Kakkonto, a traditional Japanese medicine, has anti‐inflammatory and anti‐oxidative effects. We evaluated the effect of kakkonto on vinorelbine‐induced vascular injury and its mechanism of action. Methods Human umbilical vein endothelial cells were used as the endothelial model. We compared vinorelbine‐induced cytotoxicity after pre‐incubation with the seven kakkonto components using ATP assay. Mitochondrial membrane potential was assessed using M itochondrial M embrane P otential A ssay K it. Intracellular calcium ion concentration ( [Ca 2+ ] i ) was measured with a calcium‐sensitive dye, F luo‐4 AM . eNOS and Akt phosphorylation after ephedra extract or vinorelbine treatment were investigated on western blot. Results Ephedra, a kakkonto component, protected cells against vinorelbine‐induced cytotoxicity. Ephedra extract preserved eNOS phosphorylation by increasing [Ca 2+ ] i , but it had no effect on Akt phosphorylation. The increase in [Ca 2+ ] i was mediated by Ca 2+ influx via l ‐type calcium channels. Additionally, inhibition of Ca 2+ influx or eNOS phosphorylation abolished the effects of ephedra extract. Conclusion Ephedra extract preserved eNOS phosphorylation following vinorelbine‐induced oxidative stress, thereby protecting cells from vinorelbine‐induced cytotoxicity. Moreover, the protective effect of ephedra extract is dependent on the increase of [Ca 2+ ] i and the Ca 2+ /calmodulin‐dependent signal transduction pathway.
EUVIMED